Abstract
In drug discovery, structural modifications over the lead molecule are often crucial for the development of a drug. Herein, we reported the first in vivo bioisosteric effect of phosphinolactone function in relation to the lactol group constituting the bioactive molecule: Hydroxybupropion. The preparation of phosphinolactone analogues and their antidepressant evaluation towards forced swimming test in mice showed that biological activity was regained and even strengthen. © 2010 The Royal Society of Chemistry.
Cite
CITATION STYLE
Volle, J. N., Filippini, D., Krawczy, B., Kaloyanov, N., Van Der Lee, A., Maurice, T., … Virieux, D. (2010). Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group. Organic and Biomolecular Chemistry, 8(6), 1438–1444. https://doi.org/10.1039/b919345f
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.